An intronic variant in the TP53 gene in Serbian women with cervical or ovarian cancer

Cancer Genetics and Cytogenetics

Volumn 198, Issue 2, 2010, Pages 173-175

  Malisic, Emina J ^a   Jankovic, Radmila N ^a   Radulovic, Sinisa S ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CANCER RISK; CONTROLLED STUDY; EXON; FEMALE; GENE ACTIVITY; GENE AMPLIFICATION; GENE DUPLICATION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INTRON; LETTER; NUCLEOTIDE SEQUENCE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; SEQUENCE ALIGNMENT; SERBIA; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER;

CARCINOMA; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENES, P53; HUMANS; INTRONS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; SERBIA; UTERINE CERVICAL NEOPLASMS;

EID: 77950839225     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.01.006     Document Type: Letter

References (14)

1. Sionov R.V., Haupt Y. The cellular response to p53: the decision between life and death. Oncogene 1999, 18:6145-6157.
2. Kozomora R., Jović N., Magić Z., Branković-Magić M., Minić V. p53 mutations and human papillomavirus infection in oral squamous cell carcinoma: correlation with overall survival. J Craniomaxillofac Surg 2005, 33:342-348.
3. Shih I., Kurman R.J. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004, 164:1511-1518.
4. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002, 2:594-604.
5. Wang-Gohrke S., Becher H., Kreienberg R., Runnebaum I.B., Chang-Claude J. Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age 50 years. Pharmacogenetics 2002, 12:269-272.
6. Wu X., Zhao H., Amos C.I., Shete S., Makan N., Hong W.K., Kadlubar F.F., Spitz M.R. p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst 2002, 94:681-690.
7. Gemignani F., Moreno V., Landi S., Moullan N., Chabrier A., Gutiérrez-Enríquez S., Hall J., Guino E., Peinado M.A., Capella G., Canzian F. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene 2004, 23:1954-1956.
8. Lehman T.A., Haffty B.G., Carbone C.J., Bishop L.R., Gumbs A.A., Krishnan S., Shields P.G., Modali R., Turner B.C. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res 2000, 60:1062-1069.
9. Marsh A., Spurdle A.B., Turner B.C., Fereday S., Thorne H., Pupo G.M., Mann G.J., Hopper J.L., Sambrook J.F., Chenevix-Trench G. Australian Breast Cancer Family Study; Kathleen Cuningham Foundation for Research into Familial Breast Cancer. The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia. Breast Cancer Res 2001, 3:346-349.
10. Buyru N., Tezol A., Dalay N. p53 intronic G13964C variant in colon cancer and its association with HPV. Anticancer Res 2005, 25:2767-2769.
11. Boldrini L., Gisfredi S., Ursino S., Lucchi M., Greco G., Mussi A., Donati V., Fontanini G. Effect of the p53 codon 72 and intron 3 polymorphisms on non-small cell lung cancer (NSCLC) prognosis. Cancer Invest 2008, 26:168-172.
12. Mattick J.S. Introns: evolution and function. Curr Opin Genet Dev 1994, 4:823-831.
13. Lozano G., Levine A.J. Tissue-specific expression of p53 in transgenic mice is regulated by intron sequences. Mol Carcinog 1991, 4:3-9.
14. Bergman J. The functions of introns: from junk DNA to designed DNA. Perspect Sci Christian Faith 2001, 53:170-178.